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a b s t r a c t 
Non-steroidal anti-inflammatory drugs (NSAIDs) can cause right dorsal colitis, but longitudinal clinical 
studies are lacking. This study investigates whether NSAID treated horses develop right dorsal colonic 
pathology in a clinical setting. Non-gastrointestinal hospitalized horses treated with NSAIDs > 4 days, 
and untreated hospital-owned teaching horses and non-gastrointestinal client-owned hospitalized horses 
were included. All horses were monitored over time with clinical examinations (focusing on presence of 
colic, depression, reduced appetite, unstructured feces), ultrasonographic intestinal wall measurements, 
fecal occult blood tests (semi-quantitative results), and blood analysis (total protein and albumin con- 
centrations, white blood cell and neutrophil counts). Outcomes were recorded as “ultrasonographically 
thickened right dorsal colon (RDC) walls”, “colitis” and “right dorsal colitis”. Findings over time were 
compared to baseline values and to control horses. Seventeen NSAID treated horses and 5 controls were 
included. NSAID treated horses developed thickened RDC walls (4/9), and subclinical and mild colitis 
(9/11) and right dorsal colitis (4/10), whereas all control horses remained healthy. The first changes were 
identified on treatment day 2. RDC walls of treated horses were significantly thicker compared to their 
own baseline values and compared to control horses. In conclusion, presumptive colon pathology was 
identified with a high incidence, starting early in the course of treatment, but with low severity. Ap- 
propriate monitoring should be advised throughout NSAID treatment. Additional research for noninvasive 
diagnostic tests for colon pathology is required. 
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Following treatment with non-steroidal anti-inflammatory 
rugs (NSAID’s) side effects such as renal toxicity, gastric ulceration 
nd right dorsal colitis can develop [1] . These insults to the right 
orsal colon (RDC) are typically characterized as protein-losing en- 
eropathy with RDC wall thickening and diarrhea [1] . Severe and 
dvanced cases are described [2-4] , but there is paucity in case 
escriptions of mild and subclinical right dorsal colitis. Neverthe- 
ess, there is good reason to believe that these mild and subclinical 
ases exist and are not uncommon following NSAID treatment. 
Experimental studies where healthy horses are administered 
henylbutazone have demonstrated the development of right dor- 
al colitis, with hypoproteinemia and neutropenia developing as 
arly as 3-5 days after initiation of treatment with 8.8 mg/kg BWT 
24H PO [5] , and with 2.2 mg/kg BWT q12H PO [6] . Moreover,
n vitro changes in colon tissue from healthy horses as result of 
SAID’s have been described, confirming the association between 

















































































reatment and complications [7-9] . Although providing valuable in- 
ormation in controlled settings, experimental and in vitro studies 
o not reflect a clinical setting. Additional harmful effects on the 
olon can be exerted on patients by for example hospitalization 
tress, change of feeding, changes in appetite, side effects of other 
herapies, and nosocomial disease. These can increase incidence 
nd severity and shorten the time of onset of which clinical signs 
f right dorsal colitis can appear. On the other hand, nowadays dif- 
erent and less toxic NSAID’s than phenylbutazone are commonly 
sed, possibly limiting toxicity. 
Currently longitudinal observational studies on NSAID treated 
orses in a hospitalized environment are lacking. Therefore, the 
bjective of this preliminary study is to obtain a preliminary idea 
f whether horses treated with NSAID’s in a clinical setting de- 
elop signs that can be interpreted as presence of right dorsal 
olonic toxicity. Subobjectives are to determine its incidence, sever- 
ty and onset time, and to compare RDC wall thickness during 
reatment to baseline values and to non-treated controls. 
aterials and Methods 
ase Selection 
SAID Horses 
Client-owned horses admitted to the equine teaching hospital 
f the University of Copenhagen between March 25 th to June 2 nd , 
nd August 17 th to December 11 th 2015 and matching the follow- 
ng criteria were included: 
• > 4 months old, 
• planned to stay hospitalized and receive NSAID treatment for at 
least 4 consecutive days, regardless of NSAID type, administra- 
tion route or dose, 
• no previous NSAID treatment during the last month (but horses 
receiving NSAIDs within 24H before study enrollment were ac- 
cepted), 
• hospitalized for reasons other than intestinal disease or inves- 
tigation, 
• no colic or colitis in the last month prior to study entry, 
• fecal egg count < 500 epg. 
Horses were monitored daily, starting the morning after the 
rst NSAID dose, until the day after the last NSAID administration, 
rovided they had not been discharged at this time. If possible, 
ases with thickening of the right dorsal colon (TRDC) were fol- 
owed daily until thickening subsided. 
ontrol Horses 
Client-owned horses admitted between August 17 th to Decem- 
er 11 th 2015 to the equine teaching hospital of the University of 
openhagen and with the following criteria were included: 
• > 4 months old, 
• planned to be hospitalized without receiving NSAID treatment 
for at least 7 consecutive days, 
• not treated with NSAIDs during the last month, 
• hospitalized for reasons other than intestinal disease or inves- 
tigation, 
• no colic or colitis in the last month prior to study entry, 
• fecal egg count < 500 epg. 
Horses were monitored daily, starting the morning following 
dmission, and until discharge or until initiation of NSAID treat- 
ent. 
In addition, 4 adult hospital-owned teaching horses were in- 
luded in the control group. They had not received NSAID’s or suf- 
ered from colic or colitis during the last month prior to study en- 
ry. Two of them were newly acquired teaching horses, mimicking 2 he environmental change and stress experienced by hospitalized 
orses. The two others were randomly chosen from the teaching 
erd. The teaching horses were followed for 14 days while being 
n full teaching activity. 
ata Collection 
Signalment, the primary condition (diagnosis, evolution), NSAID 
reatment (drug, administration route, dosage, duration) and other 
herapies were recorded. Every day horses were examined with fo- 
us on appetite, depression and colic. Fecal consistency was scored 
aily (1: dry and hard, 2: hard, 3: normal moist, 4: very moist, 
ut with structure, 5: soft without structure, cow pie, 6: runny, 
atery). A fecal occult blood test (FOBT) a was performed daily on 
resh, warm feces collected from the ground. Results were read 
fter 5 minutes, always in a similar room and time, and using 
 semi-quantitative scale (0: negative, no color of test line, 1: 
ery pale and difficult to see test line, 2: pale but clearly visi- 
le test line, 3: test line has similar color as control line, 4: test 
ine darker than control line; personal communication N. Kerbyson 
nd own unpublished data). Positive albumin and/or hemoglobin 
esults obtained within 24H after rectal examination and positive 
emoglobin results after upper respiratory tract surgery or bleed- 
ng were considered false positives and were discarded. Ultrasono- 
raphic measurements of the RDC wall were obtained in inter- 
ostal space (ICS) 10, 11, 12, 13 and 14 with a portable ultrasound 
canner b and a 4.5MHz curvilinear transducer c . Horses were not 
edated or clipped, and alcohol was applied to improve contact. 
t every ICS two measurements were taken, each on different still 
mages (referred to as “coupled measurements”). The mean value 
alculated from those coupled measurements was used for the 
tudy. Besides the RDC, also the duodenum, jejunum, left colon, 
ight ventral colon and cecum were scanned. Ultrasonography was 
erformed daily on NSAID treated horses and client-owned con- 
rol horses; every other day on teaching horses. In client-owned 
orses with an intravenous catheter and in teaching horses, blood 
as standardly sampled and analyzed on admission and then re- 
eated daily. Serum total protein (TP) and albumin, white blood 
ell count (WBC) and neutrophil count were measured in an exter- 
al laboratory. 
Owner informed consent was obtained for client-owned horses 
nd the hospital ethical commission approved the use of the teach- 
ng horses prior to study entry. The study was approved by the lo- 
al ethical committee of the University of Copenhagen. 
efinitions of Outcomes 
TRDC was defined as an ultrasonographic measure of the RDC 
all that has at least three out of the four following criteria: 
1) a minimal percentual increase from baseline (this increase will 
be determined by the largest percentual increase of control 
horses), 
2) a minimal absolute increase from baseline (this increase will be 
determined by the mean maximal increase from baseline values 
of control horses, and by the largest difference between cou- 
pled measurements from control cases), 
3) > the highest baseline value measured, 
4) ≥ mean + 3SD of baseline values calculated per localization. 
A horse had TRDC if these criteria were identified on at least 
ne of the locations (ICS 10, 11, 12, 13 or 14) on at least one day. 
Colitis (regardless of the section of the large intestine, but pos- 
ibly involving the RDC) was defined as presence of at least two of 
he four following criteria: 
1) TRDC as defined above, or thickening of another part of the 
large intestine visualized through ultrasonography. 
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Table 1 
Signalment of NSAID treated horses and control horses. 
NSAID treated horses ( n = 17) Control horses ( n = 5) 
N % N % 
Sex Mare 8 47% 4 80% 
Gelding 8 47% 1 20% 
Stallion 1 6% 0 0% 
Breed Saddle horse 11 65% 5 100% 
Pony 2 12% 0 0% 
Icelandic horse 4 23% 0 0% 
Mean ± SD (range) Mean ± SD (range) 
Age ( years ) 8.8 ± 5.3 (2-21) 9.8 ± 3.8 (6-14) 
Abbreviation: NSAID = non-steroidal anti-inflammatory drug; N = number of horses; 
SD = standard deviation. 
Table 2 
Overview of ultrasonographic measurements of the right dorsal colon wall of NSAID treated horses and control horses. Mean, SD and range are calculated out of 
the measures obtained for every horse per intercostal space (ICS10, ICS11, ICS12, ICS13 and ICS14). 
NSAID treated horses ( n = 9) Control horses ( n = 5) Two-sample t test with 
unequal variances ( P value) mean SD range mean SD range 
Difference between coupled 
measurements ( cm ) 
0.03 0.02 0.0-0.12 0.02 0.02 0.0-0.05 0.36 
Baseline values ( cm ) 0.20 0.03 0.14-0.29 0.21 0.02 0.16-0.24 0.41 
Minimal values ( cm ) 0.18 0.02 0.13-0.24 0.17 0.01 0.14-0.19 0.15 
Maximal values ( cm ) 0.29 0.09 0.19-0.51 0.22 0.02 0.20-0.27 0.004 ∗
Maximal absolute increase from 
baseline ( maximal value – baseline 
value; cm ) 
0.09 0.08 0.0-0.33 0.01 0.01 0.0-0.04 0.0004 ∗
Maximal percentual increase from 
baseline ( maximal value / baseline; %) 
146% 42% 100-283% 105% 7% 100-125% 0.0006 ∗
Maximal absolute increase from 
minimal values ( maximal value –
minimal value; cm ) 
0.11 0.08 0.03-0.33 0.05 0.02 0.02-0.09 0.005 ∗
Maximal percentual increase from 
minimal value ( maximal value / 
minimal value; % ) 
158% 42% 116-283% 128% 11% 111-157% 0.008 ∗



































2) A high grade FOBT (grade 3 or 4) for at least two consecutive 
days. Positive albumin and/or hemoglobin results obtained 24H 
after a rectal examination and positive hemoglobin results af- 
ter upper respiratory tract surgery or bleeding were considered 
false positives and were discarded. 
3) Decrease in one or more of the following blood values, unex- 
plained by treatments or primary disease: TP (decrease at least 
10% of baseline value and ≤ 60g/L), albumin (decrease at least 
10% of baseline value and ≤ 30g/L), WBC count (decrease at 
least 20% of baseline value and ≤ 5 ∗10 9 /L), neutrophil count 
(decrease at least 20% of baseline value and ≤ 2.5 ∗10 9 /L), 
4) Development of at least one of the following clinical signs, not 
directly explicable by the primary disease: colic, depression, re- 
duced appetite and unstructured feces (grade 5 or 6) [ 1 , 4 , 10 ]. 
Right dorsal colitis was defined with the same criteria as col- 
tis, but with certitude of RDC involvement through detection of 
RDC and absence of thickening of other intestinal sections visual- 
zed with ultrasonography. 
According to the appearance of the clinical signs, the horses 
ith evidence of colitis or right dorsal colitis were grouped as sub- 
linical or clinical. 
ata Analysis 
escriptive Statistics 
Mean, SD and range are used to describe continuous variables 
rom all horses. The number of horses with a response and with a 
ositive response and percentages are used to describe categorical 
ariables. 3 tatistical Analysis 
Variables of NSAID horses were compared to those of control 
orses. Comparisons of qualitative parameters were performed us- 
ng a logistic regression. Comparisons of quantitative parameters 
ere performed using a two-sample Wilcoxon ranksum (Mann- 
hitney) test and by assuming an unequal variance and non- 
ormal data distribution [11] . For the ultrasonographic wall thick- 
ess of the RDC over time, each time point was compared with 
ts baseline and with the corresponding time point of the control 
roup using a Welch’s test for unequal variances. Frequencies and 
roportions were compared with Fisher’s exact test [12] . P values 
 0.05 were considered significant. Commercial statistical software 
as used. d 
esults 
ase Description 
Seventeen NSAID treated horses, one client-owned control 
orse and 4 hospital-owned control horses were included in the 
tudy. Details on signalment are provided in Table 1 . Reasons for 
ospitalization of NSAID treated horses were: tongue lesion (1), 
raumatic wound on limbs (8), upper respiratory tract or sinus 
urgery (5), esophageal obstruction (1), corneal ulceration (1) and 
rthroscopy (1). The client-owned control horse was hospitalized 
or 12 days for extensive poor performance and lameness work up 
nd ophthalmological investigation. 
Horses were fed 2-3 times per day according to individually ad- 
usted feeding plans with hay and concentrated feeds. Horses were 
asted prior to surgery. 
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Horses received intravenous flunixin e (8), intravenous fol- 
owed by oral flunixin f (4), intravenous flunixin e followed by 
ral meloxicam g (4) or oral meloxicam g followed by intravenous 
unixin e (1). NSAID treatment was administered for 6.1 ± 2.4 days 
range 4-13 days). Thirteen horses received at least one of the 
reatment days more flunixin than labeled (1.3-2.2 mg/kg instead 
f 1.1 mg/kg). Meloxicam administration was never administered 
bove the labeled dose (0.6 mg/kg). Additionally, two horses re- 
eived topical diclofenacdiethylamin h for 1 and 2 days. 
ther Treatments 
Fifteen of the 17 NSAID horses received systemic antimicrobials: 
enicillin i,j (15), gentamycin k (7) and sulfadiazine/trimethoprim l 
1). Twelve underwent surgery: 11 under general anesthesia and 
 standing. Thirteen horses received at least once a sedation unre- 
ated to the surgical intervention. The client-owned control horse 
eceived local ophthalmological treatment and an intra-articular 
njection. One hospital-owned control horse was sedated once. 4 linical Signs and Fecal Consistency 
Control horses did not develop clinical signs, maintained good 
ppetite, normal fecal consistency and normal demeanor. Several 
SAID treated horses developed mild clinical signs that were not 
xplicable by the primary disease: mild colic (4), depression (4), 
ncreased fecal consistency grade (3 with grade 5), reduced ap- 
etite (3), or combinations of these clinical signs (4). 
ecal Occult Blood Test 
None of the horses showed consistently a negative FOBT 
hroughout their follow up period. Six high-grade albumin re- 
ults of control horses and 2 high-grade albumin and 2 high-grade 
emoglobin results of NSAID treated horses were discarded be- 
ause of rectal examinations taking place in the 24 hours prior to 
he test. In 7 NSAID treated horses, hemoglobin results were con- 
idered false positives because of upper respiratory tract or sinus 
leeding. 
For the remaining FOBT results, control horses only showed an 
ccasional, single-day grade 3 for hemoglobin (2) and/or albumin 
4), and never grade 4. One control horse had a grade 3 albumin 
esult for 3 consecutive days. In NSAID treated horses, grades 3 and 
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Fig. 2. Grouping of NSAID horses with regards to colitis and right dorsal colitis definitions. 
Legend: Unable to conclude = because of lacking ultrasonographic or blood examinations or changes in FOBT or blood results that were likely caused by the primary 







































t   were commonly encountered for hemoglobin (single day in 5/10 
ases; several days in a row in 2/10 cases) and/or albumin (single 
ay in 15/17 cases; several days in a row in 9/17 cases). 
ltrasonography and TRDC 
Eight of the 17 NSAID treated cases could not be scanned due 
o thick hair coat or dangerous behavior. Based on the ultrasono- 
raphic measurements ( Table 2 ), the definition of TRDC has been 
et as an ultrasonographic measure of the RDC wall that has at 
east three out of the four following criteria: 
1) minimal percentual increase: 157 % of baseline value, 
2) minimal absolute increase: 0.05 cm, 
3) > 0.29 cm, 
4) ≥ mean + 3SD of baseline values calculated per localization. 
Four out of the 9 scanned NSAID treated horses (44 %) devel- 
ped TRDC whereas control horses remained all with a normal 
DC wall thickness. TRDC was detected as early as day 3 of treat- 
ent in 1 horse, on day 4 in 2 horses and day 6 in one horse. Dur-
ng post treatment monitoring, RDC wall measurements decreased 
gain ( Fig. 1 - 3). 
In one horse (case 16) no TRDC developed, but a mild left 
olonic (baseline 0.21 cm, peak 0.35 cm) and jejunal thickening 
baseline 0.17 cm, peak 0.33 cm) was noted. No other horses devel- 
ped thickening of other gastro-intestinal sections than the RDC. 5 lood Analysis 
Due to absence of a catheter, one control horse and 6 treated 
orses could not be sampled throughout their treatment period. 
he 4 remaining control horses showed no changes in blood pa- 
ameters. In one NSAID treated horse all 4 parameters dropped 
t day 13 (TP 48.3 g/L, albumin 27.9 g/L, WBC 2.2 ∗10 9 /L, neu-
rophils 1.3 ∗10 9 /L). Another NSAID treated horse developed neu- 
ropenia (2.5 ∗10 9 /L) on day 4. These findings were unrelated to the 
rimary conditions (traumatic wound). 
olitis and Right Dorsal Colitis 
None of the control horses showed indications of colitis or right 
orsal colitis. Nine horses (9/11 = 82 %, including all 4 horses 
ith TRDC) fulfilled the criteria for the colitis definition and 4 
4/10 = 44 %, including all 4 horses with TRDC) for the right dorsal 
olitis definition ( Fig. 2 and 3 ). Time of onset of recorded changes
as variable amongst horses, but the first changes (typically de- 
ression and FOBT positive results) were identified as early as day 
 of NSAID treatment. 
tatistical Comparison 
Sex and age were not different between treated and non- 
reated groups. Maximal RDC wall thickness, maximal increases 
rom baseline, and maximal increases from minimal values dur- 
ng treatment from treated horses were significantly higher than 
hose of control horses ( Table 2 ). At treatment day 2, RDC walls
rom treated horses were significantly thinner compared to con- 
rol horses in ICS space 10 and 11 ( P 0.009 and P 0.04, respec-
G. van Galen, C. Saegerman, S. Hyldahl Laursen et al. Journal of Equine Veterinary Science 101 (2021) 103451 
Fig. 3. Criteria and timing of development of colitis following NSAID treatment. 
Legend: t = treatment day, P = post treatment day; Depr = depression; FOBT = fecal occult blood test; TP = total protein; A = albumin; WBC = white blood cells; 











































ively). However, they were significantly thicker compared to con- 
rol horses at treatment day 3 in ICS space 12 ( P 0.02) and day 5
n ICS space 10, 11 and 14 ( P 0.008, P 0.047 and P 0.05, respec-
ively). At day 5 they were also significantly thicker compared to 
heir own baseline values in ICS space 10 and 11 ( P < 0.001 and P
.05, respectively; Fig. 4 ). The noted changes in clinical signs, blood 
arameters and FOBT results showed no statistically differences be- 
ween groups. 
iscussion 
In contrast to earlier experimental studies, this is the first longi- 
udinal study describing the effects of NSAID’s on the equine colon 
n a clinical setting. It shows a high incidence, yet low severity, 
f right dorsal colitis developing early in the course of treatment. 
linical studies are inherently complicated by absence of a gold 
tandard for diagnosing right dorsal colitis and absence of a clear 
efinition of right dorsal colitis in literature. As a result, for the 
resent study three outcomes (TRDC, colitis and right dorsal col- 
tis) were included to discern different forms of colon pathology. 
nterestingly, TRDC always occurred in conjunction with clinical 
igns, and can therefore be suggested a strong indicator for right 
orsal colitis. This is also in line with the current existing litera- 6 ure, where the diagnosis of right dorsal colitis is typically made 
ltrasonographically by detecting TRDC [1-2] . Not all cases defined 
s having colitis had TRDC and thus could not be concluded to suf- 
er from right dorsal colitis, some of which were due to missing 
ltrasonographic data. In these cases important differential diag- 
oses were antimicrobial induced colitis, nutritional changes, stress 
nd hospital acquired infections. All can give rise to clinical signs, 
hanges in blood analysis and changes in FOBT similar to right dor- 
al colitis. Also thickening of colon walls can occur, however, thick- 
ning of only the RDC wall, as is typically seen in right dorsal col- 
tis, would be unlikely. 
Unfortunately, in several NSAID treated cases no outcome 
TRDC, colitis or right dorsal colitis) could be concluded because of 
bsent or temporarily unreliable complementary examinations, un- 
erestimating the incidences of colon pathology in this study. Still, 
RDC and subclinical or mild clinical colitis and right dorsal coli- 
is were identified in a several of NSAID treated horses. This was 
one through use of indicators of colon pathology that are widely 
nd easily available in practice: clinical signs, FOBT, abdominal ul- 
rasonography and blood analysis. The clinical signs used and de- 
ected in this study (colic, depression, reduced appetite and un- 
tructured feces) are nonspecific, especially when mild, can be as- 
ociated to many different conditions, and cannot be used to dif- 
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Fig. 4. a-e Boxplot with the ultrasonographic wall thickness of the right dorsal colon over time of 9 NSAID treated horses and 5 untreated control horses at the different 
intercostal spaces (ICS): ICS10 (A), ICS11 (B), ICS12 (C), ICS13 (D), ICS14 (E). 
Legend: C = Control horses; T = Treated horses; ∗ = significant difference between C & T; 





















erentiate between different forms of colitis. Moreover, they might 
ave introduced bias in this study, because they can be triggered 
y the primary disease or by other side effects of NSAID therapy 
uch as gastric ulcers. To reduce bias as much as possible, coli- 
is and right dorsal colitis definitions were never based on clinical 
igns alone and clinical signs were only used when they were not 
xplicable by the primary disease. Despite the above-mentioned 
ifficulties, clinical signs are of major importance to determine 
everity of colon affection (subclinical – mild – severe). 
The FOBT allowed differentiating between groups by serial 
esting and the use of the semi-quantitative test result read- 7 ng, especially for albumin. It should be recognized that positive 
emoglobin results can originate from lesions from the upper res- 
iratory tract and/or the entire length of the gastro-intestinal tract, 
ncluding from gastric ulcers. Positive albumin results, on the other 
and, are believed to be caused by lesions in the large intestines. 
In the present study the repeatability of ultrasonographic mea- 
urements was not assessed with statistical methods, but was es- 
eemed good based on the small differences between the coupled 
easurements. These differences were also found to be similar to 
hose previously described for other intestinal sections [13] . Since 
ntestinal wall measurements vary significantly between studies 

































































































13] , the current study defined TRDC on self-established criteria 
nd compared to baseline values. Some horses with TRDC had a 
all thickness only slightly above or even within reported refer- 
nce values. Similar cases may easily be overlooked in practice 
ithout comparison to baseline values and/or in the absence of 
erial measurements throughout NSAID treatment. The ultrasono- 
raphic criteria developed and used in this study to detect TRDC 
minimal percentual increase of 157 % of baseline value over time, 
inimal absolute increase of 0.05 cm over time, and a thickness 
f > 0.29 cm at any moment), can be suggested as new ultrasono- 
raphic guidelines for clinical use. Furthermore, false negatives of 
RDC or right dorsal colitis can occur because of invisibility of the 
ontralateral RDC wall, or ante-rupture thinning [2] . Ultrasonogra- 
hy is believed helpful to diagnose overt right dorsal colitis [2] , 
nd appeared valuable in the current study to detect subclinical 
nd mild cases. 
In previous experimental studies, decreases in plasma albu- 
in concentration [ 5 , 6 , 14 ], plasma protein concentration [ 6 , 14 ] and
eutrophil count [5] were detected following NSAID treatment. 
lso, many clinicians only confirm a diagnosis of right dorsal col- 
tis when there is presence TRDC together with a decline in al- 
umin concentrations. In this study important declines were only 
ound in 2 treated horses, suggesting that right dorsal colitis, es- 
ecially subclinical, can occur without significant drop in albumin 
oncentrations. Interfering factors prohibiting detection of declines 
re inflammatory changes related to the primary disease, fluid ad- 
inistration, primary disease or complications, rendering the use 
f blood parameters less helpful in clinical settings. 
Overall, this study emphasizes that the use and interpretation 
f indicators of RDC pathology is not always straightforward. How- 
ver, our results support the use of baseline values and serial mea- 
urements for all applied indicators. The first changes in the cur- 
ent study could be detected as early as day 2 of treatment and 
RDC as from day 3. This time of onset is similar or slightly ear-
ier than recorded in previous experimental studies where findings 
ere detected earliest at day 3 [5] or day 5 [6] . In contrast to pre-
ious studies [2-6] , no severe disease occurred in any of the horses. 
his might be explained by the use of less toxic NSAID’s (flunixin 
nd meloxicam). Despite the mild clinical impact, the incidence of 
astrointestinal side effects was high though. 
Limitations of this study include absence of a diagnostic gold 
tandard for right dorsal colitis, some missing or temporarily un- 
eliable complementary examinations and the fact that the study 
as not executed in a blind manner. Another limitation is also the 
mall and heterogenous study population with a relatively short 
uration of NSAID treatment, and the small control group. How- 
ver, this study was only meant as a preliminary study to de- 
elop a better understanding about whether colon problems are 
ccurring in a clinical population treated with NSAIDs. Despite its 
any limitations, this study delivers interesting information about 
hanges in colon health over time in hospitalized horses treated 
ith NSAIDs. Moreover, one should be cautious to conclude that 
he changes in colon health in the treated horses are caused by 
SAIDs as this study is an observational study and is not evaluat- 
ng causation, and differences in severity of disease between con- 
rol and treatment groups or treatment differences, could have af- 
ected outcome. The findings of this study need to be confirmed 
nd further studied in depth with future larger clinical studies that 
ill address the shortcomings of the current study. 
onclusions 
In conclusion, a high incidence of mild colon pathology was en- 
ountered. Changes examinations that are assessing colon health 
ere detected after as early as 2 days of NSAID treatment. Stud- 
es including a larger study population and longer treatment du- 8 ation are needed to confirm these findings. NSAID’s are widely 
sed and necessary drugs in equine medicine, but considering the 
ide effects we recommend appropriate monitoring. Especially ul- 
rasonography revealed useful, and new guidelines of ultrasono- 
raphically assessing right dorsal colon thickness can be suggested 
ased on this study. Future research should be aimed to develop 
dditional non-invasive diagnostic modalities and to confirm these 
ndings. 
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